Stay updated with breaking news from Douglas Cliff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study in the journal Obesity evaluated the impact of new anti-obesity medications (AOMs) on cardiovascular disease (CVD) among obese individuals, finding that these medications reduce the risk of CVD complications, particularly heart failure and atrial fibrillation.
A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health metrics over four years. The study also highlighted the safety and tolerability of semaglutide across different BMI categories.
Losing a lot of weight quickly sounds like a dream, but one downside is saggy, wrinkly skin. Here's what experts say about "Ozempic neck."
Delta flight leaving Atlanta and headed to Barcelona, Spain was forced to land over severe passenger diarrhea